Searchable abstracts of presentations at key conferences in endocrinology

ea0077lb39 | Late Breaking | SFEBES2021

Metabolomic analysis of succinate dehydrogenase subunit knockout in phaeochromocytoma and neuroblastoma cell lines

Salsbury Grace , Read Jordan E , Morales Valle , Hall Charlotte L , Lim Eugenie S , Akker Scott A , Bianchi Katiuscia , Chapple Paul

Loss of function of succinate dehydrogenase (SDH), caused by mutations in each of the 4 subunits – SDHA/B/C and D – is associated with development of phaeochromocytomas and paragangliomas (PPGLs). The mutations lead to loss of enzymatic activity and subsequent accumulation of the oncometabolite succinate, a driver of tumourigenesis. It is well established but poorly understood why mutations in SDHB are associated with more aggressi...

ea0050p302 | Neuroendocrinology and Pituitary | SFEBES2017

Unaffected genetic testing in families at risk of phaeochromocytoma or paraganglioma

Izatt Louise , Carroll Paul , McGowan Barbara , Powrie Jake , Moonim Mufaddal , Jacques Audrey , Obholzer Rupert , Whitelaw Benjamin , Kumar Ajith , Akker Scott

75% of patients presenting with a phaeochromocytoma (PCC) or paraganglioma (PGL) have no relevant family history, but a germline pathogenic variant is identified in 30–40%. In our genetic endocrine clinic, over 80% of patients with malignant PCC or PGL have SDHA/SDHB/SDHC/SDHD/MAX or FH pathogenic variants identified, confirming high heritability in severe disease.We describe a series of seven patients from fiv...

ea0050p302 | Neuroendocrinology and Pituitary | SFEBES2017

Unaffected genetic testing in families at risk of phaeochromocytoma or paraganglioma

Izatt Louise , Carroll Paul , McGowan Barbara , Powrie Jake , Moonim Mufaddal , Jacques Audrey , Obholzer Rupert , Whitelaw Benjamin , Kumar Ajith , Akker Scott

75% of patients presenting with a phaeochromocytoma (PCC) or paraganglioma (PGL) have no relevant family history, but a germline pathogenic variant is identified in 30–40%. In our genetic endocrine clinic, over 80% of patients with malignant PCC or PGL have SDHA/SDHB/SDHC/SDHD/MAX or FH pathogenic variants identified, confirming high heritability in severe disease.We describe a series of seven patients from fiv...

ea0082p17 | Poster Presentations | SFEEU2022

Brown tumour of the palate heralding a diagnosis of severe primary hyperparathyroidism in a young male

Boughton Charlotte , Lau Eunice , Scott Francis , Kennedy Robert , Basyuni Shadi , Santhanam Vijayarajan , Das Tilak , Fish Brian , Stokes Victoria , Casey Ruth

Case history: An 18 year old male student presented to the dentist with an eight week history of left-sided facial pain and swelling. He was subsequently referred to the maxillofacial team. His only previous medical encounter was for a traumatic right humerus fracture following a roller-skating injury. He took no regular medication. His father died of an unknown malignant process several years previous and family history was otherwise unremarkable. On questioning, the patient ...

ea0086p261 | Neuroendocrinology and Pituitary | SFEBES2022

A rare case of multicentric glioblastoma causing panhypopituitarism: A case report

Shafiq Shahriar , Sim Yi Tao , Thayyil Sheena , Gohil Shailesh , Bhake Ragini , Reddy Narendra L , Scott Ian , Robertson Iain , Levy Miles

Introduction: Glioblastoma, an aggressive intracranial tumour usually is a solitary lesion and not commonly located in the sella turcica. Panhypopituitarism due to multicentric glioblastoma can present with a challenging clinical picture masking or delaying the underlying diagnosis. Case presentation: 58 year old female presented with marked behavioural change, reduced appetite, nausea, polyuria & increased thirst over 4-6 weeks precipitating into an...

ea0090rc5.4 | Rapid Communications 5: Adrenal and Cardiovascular Endocrinology 1 | ECE2023

Primary bilateral macronodular adrenal hyperplasia (PBMAH) is likely a genome instability disease due to ARMC5’s role in resolving transcription-replication conflict

Lao Linjiang , Bourdeau Isabelle , Gagliardi Lucia , He Xiao , Torpy David , Scott Hamish , Lacroix Andre , Luo Hongyu , Wu Jiangping

ARMC5 mutations are associated with PBMAH risks, but the ARMC5 action mechanism remains unknown. We discovered that ARMC5 was part of a novel ubiquitin ligase (E3) specific for RPB1, the largest Pol II subunit. ARMC5 deletion significantly reduced RPB1 ubiquitination and increased RPB1 accumulation. Surprisingly, the degradation of not only RPB1 but all the 12 subunits of Pol II was compromised in the absence of ARMC5, suggesting that this E3 acts on RPB1 and molecules in its ...

ea0065p289 | Neuroendocrinology | SFEBES2019

Does volumetric MRI (3D-SGE sequence) imaging enhance diagnostic rates in Cushing’s disease?

Gul Fidan , Stiles Craig , Dorward Neil , Grieve Joan , Druce Maralyn , Akker Scott , Waterhouse Mona , Evanson Jane , Drake William

Tumour localisation in Cushing’s disease (CD) can be challenging; most are microadenomas and 50% are <5 mm in diameter. They are, therefore, often difficult to detect by conventional MRI. Volumetric MRI (3D-SGE, spoiled-gradient echo 3D sequence) is a high spatial resolution scanning technique which uses very thin slices (1 mm). Theoretically, this increases the probability of finding small pituitary lesions when compared to conventional (spin-echo, SE) MRI techniques...

ea0065p321 | Neuroendocrinology | SFEBES2019

A suprasellar germ cell tumour presenting with cranial diabetes insipidus

Samarasinghe Suhaniya , Scott Rebecca , Seckl Michael J , Gonzalez Mike , Harvey Richard , Unsworth Nick , Hatfield Emma , Martin Niamh , Meeran Karim

A 30-year-old female presented to her general practitioner with a three-month history of fatigue, visual disturbance, polydipsia and dizziness. She was treated for iron deficiency anaemia, but re-presented two-months later with new-onset headache and worsening visual disturbance. Previously, she had childhood leukaemia, treated in Brazil with no cranial irradiation. On examination there was left eye loss of light/dark perception and right temporal vision loss. She was referred...

ea0065p365 | Reproductive Endocrinology and Biology | SFEBES2019

Derivatisation of 5α-dihydrotestosterone enhances sensitivity of analysis of human plasma by liquid chromatography tandem mass spectrometry

Faqehi Abdullah , Denham Scott , Naredo-Gonzalezb Gregorio , Cobice Diego , Sabil Ghazali , Upreti Rita , Gibb Fraser , Homer Natalie , Andrew Ruth

Liquid Chromatography tandem mass spectrometry (LC–MS/MS) is gold-standard for androgen analysis in biological fluids, superseding immunoassays in specificity, particularly at low concentrations. While LC–MS/MS is well established for analysis of testosterone (T) and androstenedione (A4), 5α-dihydrotestosterone (DHT) presents greater analytical challenges. DHT circulates at low nanomolar concentrations in men and lower in women, ionising inefficiently. Thus, eve...

ea0041ep1128 | Thyroid cancer | ECE2016

Nuclear cysteine cathepsins in thyroid carcinomas

Al-Hashimi Alaa , Tedelind Sofia , Szumska Joanna , Dierkes N Kim , Pinzaru Alexandra , Burden Roberta , Scott Christopher , Fuhrer Dagmar , Brix Klaudia

Cysteine cathepsins are endo-lysosomal proteases that play crucial roles in thyroid physiology. However, in thyroid cancer, cathepsin B is overexpressed and secreted into the extracellular space, thus promoting migratory phenotypes of thyroid carcinoma cells through excessive extracellular matrix degradation. In addition, we have shown that N-terminally truncated forms of cathepsins B and V which lack the signal peptide and parts of the pro-peptide are localized to the nuclei ...